Hem › Lungcancer › Virginia › Arlington
Kliniska studier för Lungcancer i Arlington, VA
41 studier för Lungcancer söker deltagare vid platser i och runt Arlington (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RekryterarFas 3
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5 mi bort
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RekryterarFas 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi bort
Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)
RekryterarFas 2
- Virginia Cancer Specialists (VCS) ( Site 0408), Fairfax · 11 mi bort
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
RekryterarFas 3
- Virginia Cancer Specialists, Fairfax · 11 mi bort
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
RekryterarFas 3
- Virginia Cancer Specialists, Fairfax · 11 mi bort
A Study of PHN-012 in Patients With Advanced Solid Tumors
RekryterarFas 1
- PHN-012-001 Site, Fairfax · 11 mi bort
Phase 1 Study of PF-08046033 in Advanced Solid Tumors
RekryterarFas 1
- Inova Schar Cancer Infusion Pharmacy, Fairfax · 11 mi bort
- Inova Schar Cancer, Fairfax · 11 mi bort
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
RekryterarFas 2
- Research Site, Fairfax · 11 mi bort
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
RekryterarFas 2/3
- Virginia Cancer Specialists - Arlington, Arlington
- Virginia Cancer Specialists, Fairfax · 11 mi bort
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RekryterarFas 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi bort
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
RekryterarFas 1/2
- Next Oncology Virginia Cancer Specialist, Fairfax · 11 mi bort
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
RekryterarFas 1
- NEXT - Virginia, Fairfax · 11 mi bort
BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)
RekryterarFas 3
- Virginia Cancer Specialists, Fairfax · 11 mi bort
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
RekryterarFas 1/2
- NEXT Virginia, Fairfax · 11 mi bort
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
RekryterarFas 1
- Virginia Cancer Specialists, Fairfax · 11 mi bort
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RekryterarFas 3
- USO - Virginia Cancer Specialists, Fairfax · 11 mi bort
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
RekryterarFas 1
- USO-Virginia Cancer Specialists, PC, Fairfax · 11 mi bort
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
RekryterarFas 1/2
- Avenzo Therapeutics Recruiting Site, Fairfax · 11 mi bort
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
RekryterarFas 1
- NEXT Oncology, Fairfax · 11 mi bort
The Vanguard Study: Testing a New Way to Screen for Cancer
RekryterarFriska volontärer välkomna
- Inova Schar Cancer Institute, Fairfax · 11 mi bort
- Inova Fair Oaks Hospital, Fairfax · 11 mi bort
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
RekryterarFas 3
- Virginia Cancer Specialists, Fairfax · 11 mi bort
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
RekryterarFas 3
- Virginia Cancer Specialists, Fairfax · 11 mi bort
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
RekryterarFas 3
- Inova Schar Cancer Institute, Fairfax · 11 mi bort
- Inova Fair Oaks Hospital, Fairfax · 11 mi bort
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
RekryterarFas 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · 11 mi bort
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
RekryterarFas 1/2
- NEXT Virginia, Fairfax · 11 mi bort
Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer
RekryterarFas 1
- NEXT Virginia, Fairfax · 11 mi bort
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
RekryterarFas 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi bort
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
RekryterarFas 1
- NEXT Virginia, Fairfax · 11 mi bort
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
RekryterarFas 1
- Research Site, Fairfax · 11 mi bort
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RekryterarFas 2
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5 mi bort
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
RekryterarFas 1
- NEXT Oncology Virginia, Fairfax · 11 mi bort
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
RekryterarFas 1/2
- NEXT Virginia, Fairfax · 11 mi bort
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
RekryterarFas 1/2
- Next Oncology Virginia, Fairfax · 11 mi bort
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
RekryterarFas 1/2
- NEXT Oncology, Fairfax · 11 mi bort
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
RekryterarFas 2
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5 mi bort
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RekryterarFas 2/3
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5 mi bort
A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma
RekryterarFas 2
- Inova Fairfax Hospital, Fairfax · 11 mi bort
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
RekryterarFas 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi bort
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
RekryterarFas 1/2
- NEXT Virginia, Fairfax · 11 mi bort
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
RekryterarFas 1
- NEXT Virginia, Fairfax · 11 mi bort
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
RekryterarFas 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi bort
Lungcancer-studier i andra städer
- Houston, TX78 studier
- Boston, MA62 studier
- New York City, NY60 studier
- Los Angeles, CA45 studier
- Washington, DC41 studier
- Chicago, IL41 studier
- Nashville, TN40 studier
- Baltimore, MD40 studier
- St. Louis, MO39 studier
- Columbus, OH37 studier
- Philadelphia, PA36 studier
- Seattle, WA33 studier
Andra studier i Arlington
- Icke-småcellig lungcancer104 studier
- Metastaserande cancer53 studier
- Kolorektal cancer52 studier
- Cancer (alla typer)48 studier
- Bröstcancer46 studier
- Äggstockscancer46 studier
- Endometriecancer39 studier
- Bukspottkörtelcancer33 studier
- Plattenepitelcancer i huvud och hals26 studier
- Småcellig lungcancer23 studier
- Triplenegativ bröstcancer20 studier
- Magsäckscancer20 studier
Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.